Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 110 (5), 460-3

[Adjuvant Stereotactic Low Energy Radiation Therapy of Exudative Age-Dependent Macular Degeneration (Oraya System)]

[Article in German]
Affiliations

[Adjuvant Stereotactic Low Energy Radiation Therapy of Exudative Age-Dependent Macular Degeneration (Oraya System)]

[Article in German]
S Pollithy et al. Ophthalmologe.

Abstract

With respect to the increasing number of patients and the risk and burden for patients caused by injections, a reduction in the number and frequency of injections with vascular endothelial growth factor (VEGF) inhibitors in exudative age-related macular degeneration (ARMD) is desirable. Stereotactic low-voltage x-ray irradiation seems to be a promising approach. For this purpose the Oraya system is available and has shown positive results in initial studies. Pending presentation of phase II and III study data this adjuvant irradiation should only be used in clinical trials.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Ophthalmology. 1999 Dec;106(12):2239-47 - PubMed
    1. Am J Ophthalmol. 1999 May;127(5):574-8 - PubMed
    1. Br J Ophthalmol. 1993 May;77(5):265-73 - PubMed
    1. Am J Ophthalmol. 2004 Nov;138(5):818-28 - PubMed
    1. Klin Monbl Augenheilkd. 2000 Feb;216(2):112-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback